Orchestra BioMed Holdings Inc - fluxo de caixa trimestral (NASDAQ:OBIO) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -13.54 M-16.62 M-15.53 M-14.55 M-2.27 M -48.96 M Cash from investing activities -3.75 M13 M16.36 M-38.58 M-17.71 M -26.94 M Cash from financing activities 13.95 M-296 K-428 K76.4 M12.66 M 88.33 M Free cash flow -13.64 M-16.73 M-15.56 M-14.86 M-2.3 M -49.45 M

Notícias

Jefferies reduz preço-alvo da Orchestra BioMed devido a custos de financiamento

Chardan reitera classificação de compra para Orchestra BioMed com foco em estudos

Chardan reiterates Orchestra BioMed stock rating on trial focus

Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates

Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates

Orchestra BioMed to present hypertension therapy data at medical meetings

TD Cowen inicia cobertura da Orchestra BioMed com recomendação de compra

TD Cowen initiates Orchestra BioMed stock with Buy rating on novel medical device portfolio

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates

ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Medtronic recebe aprovação da FDA para dispositivo de incontinência urinária